Stago Establishes Stake in Thrombin Generation Through Acquisition of Thrombinoscope BV
July 1, 2011, Parsippany, NJ, USA – Diagnostica Stago, Inc. (DSI), recently finalized the acquisition of Thrombinoscope BV, based in Maastri...
Diagnostica Stago, Inc. Introduces STA® Staclot® DRVV Lupus Anticoagulant Assays
October 7, 2010, Parsippany, NJ, USA – Diagnostica Stago, Inc. is pleased to announce the addition of STA® Staclot® DRVV Screen and STA Stac...
Cellquant and Redquant Kits Now Available Exclusively Through Diagnostica Stago
October 1, 2010, Parsippany, NJ, USA – Diagnostica Stago, Inc. (DSI) announces exclusive distribution of the Biocytex Cellquant PNH and Redq...
Stago’s Ecarin Chromogenic Assay Provides Precise Research-Use DTI Results
October 1, 2010, Parsippany, NJ, USA – The ecarin chromogenic assay (ECA) from Diagnostica Stago, Inc. (Stago), is a highly-specific tool fo...
Stago’s VASP Assay Used For P2Y12 Biomarker Studies
October 1, 2010, Parsippany, NJ, USA – The VASP flow cytometry assay kit from Diagnostica Stago, Inc. (Stago), examines platelet responsiven...
Diagnostica Stago, Inc., (DSI) is an industry leader in the science of hemostasis and thrombosis. Stago provides the total commitment of global resources and responsiveness, coupled with cutting edge technology and reliability. DSI is dedicated to continually developing and providing the very best hemostasis products, technical support, and services.
Our primary mission is to provide laboratory and healthcare professionals with reliable, powerful and innovative hemostasis diagnostic instruments and reagents. We consistently strive to improve methods for prevention, understanding, diagnostic, treatment and follow-up of coagulation-related disorders.
2/09/12 - 2/10/12
4/01/12 - 4/06/12
4/22/12 - 4/28/2012
Did you know?
Factor VII and Protein C are the first factors decreased by the antivitamin K treatment (half-life : 4-6 hours).
http://www.stagojobs.com/